Evidence map›Paper›PMID 35633856›Full record

ReviewCurrent urology2022

The value of sestamibi single-photon emission computed tomography/computed tomography in differentiating and staging renal cell carcinomas: A systematic review.

Abdalla Ali Deb, Ayman Agag, Naufal Naushad, Rajbabu Krishnamoorthy, Hosam Serag

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Abdalla Ali DebDepartment of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.
Ayman AgagDepartment of Urology, Frimley Park Hospital, Camberely, UK.
Naufal NaushadDepartment of Urology, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Rajbabu KrishnamoorthyDepartment of Urology, Guthrie Corning Hospital, Corning, New York, USA.
Hosam SeragDepartment of Urology, University Hospitals Birmingham, Birmingham, UK.
Aberdeen Royal Infirmary · GBCorning (United States) · USFrimley Park Hospital · GBManchester University NHS Foundation Trust · GBNIHR Surgical Reconstruction and Microbiology Research Centre · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Misdiagnosis of benign renal neoplasms can lead to unnecessary surgical resections, which increases the risk of other morbidities and mortality. Therefore, it is crucial to find a diagnostic modality for differentiation between benign and malignant renal masses. In the current study, we summarized published pieces of evidence concerning the use of technetium-99m (

Indexed as

99mTc-sestamibiAngiomyolipomaOncocytomaRenal cell carcinomaSystematic review

Identifiers

PMID35633856
PMCPMC9132183
OpenAlexW4213170679

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.